102 related articles for article (PubMed ID: 20932865)
1. Phage display technology for stem cell delivery and systemic therapy.
Staquicini FI; Sidman RL; Arap W; Pasqualini R
Adv Drug Deliv Rev; 2010 Sep; 62(12):1213-6. PubMed ID: 20932865
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial vascular targeting in translational medicine.
Staquicini FI; Moeller BJ; Arap W; Pasqualini R
Proteomics Clin Appl; 2010 Jul; 4(6-7):626-32. PubMed ID: 21137081
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. targeted drug delivery to hepatocarcinoma in vivo by phage-displayed specific binding peptide.
Du B; Han H; Wang Z; Kuang L; Wang L; Yu L; Wu M; Zhou Z; Qian M
Mol Cancer Res; 2010 Feb; 8(2):135-44. PubMed ID: 20145035
[TBL] [Abstract][Full Text] [Related]
5. Novel challenges in exploring peptide ligands and corresponding tissue-specific endothelial receptors.
Balestrieri ML; Napoli C
Eur J Cancer; 2007 May; 43(8):1242-50. PubMed ID: 17449238
[TBL] [Abstract][Full Text] [Related]
6. Phage library-screening: a powerful approach for generation of targeting-agents specific for normal pancreatic islet-cells and islet-cell carcinoma in vivo.
Ueberberg S; Schneider S
Regul Pept; 2010 Feb; 160(1-3):1-8. PubMed ID: 19958795
[TBL] [Abstract][Full Text] [Related]
7. Molecular addresses of tumors: selection by in vivo phage display.
Li XB; Schluesener HJ; Xu SQ
Arch Immunol Ther Exp (Warsz); 2006; 54(3):177-81. PubMed ID: 16736105
[TBL] [Abstract][Full Text] [Related]
8. Identification of homing peptides using the in vivo phage display technology.
Rivinoja A; Laakkonen P
Methods Mol Biol; 2011; 683():401-15. PubMed ID: 21053146
[TBL] [Abstract][Full Text] [Related]
9. A specific heptapeptide from a phage display peptide library homes to bone marrow and binds to primitive hematopoietic stem cells.
Nowakowski GS; Dooner MS; Valinski HM; Mihaliak AM; Quesenberry PJ; Becker PS
Stem Cells; 2004; 22(6):1030-8. PubMed ID: 15536193
[TBL] [Abstract][Full Text] [Related]
10. Discovery of human antibodies against the C5aR target using phage display technology.
Huang L; Sato AK; Sachdeva M; Fleming T; Townsend S; Dransfield DT
J Mol Recognit; 2005; 18(4):327-33. PubMed ID: 15706605
[TBL] [Abstract][Full Text] [Related]
11. Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies.
Mimeault M; Hauke R; Batra SK
Clin Pharmacol Ther; 2007 Sep; 82(3):252-64. PubMed ID: 17671448
[TBL] [Abstract][Full Text] [Related]
12. Genetic selection of phage engineered for receptor-mediated gene transfer to mammalian cells.
Kassner PD; Burg MA; Baird A; Larocca D
Biochem Biophys Res Commun; 1999 Nov; 264(3):921-8. PubMed ID: 10544031
[TBL] [Abstract][Full Text] [Related]
13. Identification of cancer targets and therapeutics using phage display.
Brissette R; Prendergast JK; Goldstein NI
Curr Opin Drug Discov Devel; 2006 May; 9(3):363-9. PubMed ID: 16729733
[TBL] [Abstract][Full Text] [Related]
14. Identification of receptor ligands with phage display peptide libraries.
Koivunen E; Arap W; Rajotte D; Lahdenranta J; Pasqualini R
J Nucl Med; 1999 May; 40(5):883-8. PubMed ID: 10319765
[TBL] [Abstract][Full Text] [Related]
15. Application of phage display to discovery of tumor-specific homing peptides: developing strategies for therapy and molecular imaging of cancer.
Seung-Min L; Gil-Suk Y; Eun-Sang Y; Tae-Gyun K; In-San K; Byung-Heon L
Methods Mol Biol; 2009; 512():355-63. PubMed ID: 19347288
[TBL] [Abstract][Full Text] [Related]
16. On the synergistic effects of ligand-mediated and phage-intrinsic properties during in vivo selection.
Driessen WH; Bronk LF; Edwards JK; Proneth B; Souza GR; Decuzzi P; Pasqualini R; Arap W
Adv Genet; 2010; 69():115-33. PubMed ID: 20807605
[TBL] [Abstract][Full Text] [Related]
17. Identification of synovium-specific homing peptides by in vivo phage display selection.
Lee L; Buckley C; Blades MC; Panayi G; George AJ; Pitzalis C
Arthritis Rheum; 2002 Aug; 46(8):2109-20. PubMed ID: 12209516
[TBL] [Abstract][Full Text] [Related]
18. Mouse thymus targeted peptide isolated by in vivo phage display can inhibit bioactivity of thymus output in vivo.
Yang Yu ; Zizheng Wang ; Tongxin Du
J Biomol Screen; 2008 Dec; 13(10):968-74. PubMed ID: 18978306
[TBL] [Abstract][Full Text] [Related]
19. Peptide-mediated targeting to tumor blood vessels of lung cancer for drug delivery.
Lee TY; Lin CT; Kuo SY; Chang DK; Wu HC
Cancer Res; 2007 Nov; 67(22):10958-65. PubMed ID: 18006841
[TBL] [Abstract][Full Text] [Related]
20. Phage peptide display.
Newton J; Deutscher SL
Handb Exp Pharmacol; 2008; (185 Pt 2):145-63. PubMed ID: 18626602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
